Michael Anthony Romanos

Michael Anthony Romanos

Director/Board Member at Lifearc

Commercial Services
Health Technology
Consumer Services

Profile

Michael Anthony Romanos is the founder of Crescendo Biologics Ltd.
(founded in 2007) and Microbiotica Ltd.
(founded in 2016), where he held the titles of Chief Executive Officer and Director, respectively.
He is currently the Director at The Bioindustry Association (since 2020) and a Trustee at Lifearc (since 2016).
Dr. Romanos previously worked as Vice President-Discovery Technology at GSK Plc, Senior Scientist at Wellcome Foundation Ltd, and Member at The Institute of Directors (United Kingdom).
He holds a doctorate degree from Imperial College London and an undergraduate degree from the University of Cambridge.

Michael Anthony Romanos active positions

CompaniesPositionStart
Director/Board Member 2016-02-29
Director/Board Member 2019-12-31
All active positions of Michael Anthony Romanos

Former positions of Michael Anthony Romanos

CompaniesPositionEnd
Founder 2022-12-31
Corporate Officer/Principal -
GSK PLC Corporate Officer/Principal -
Wellcome Foundation Ltd Chief Tech/Sci/R&D Officer -
Chief Executive Officer -
See the detail of Michael Anthony Romanos's experience

Training of Michael Anthony Romanos

University of Cambridge Undergraduate Degree
Imperial College London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Anthony Romanos's experience

Connections

52

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
GSK PLC

Health Technology

Private companies6

Commercial Services

Wellcome Foundation Ltd

Commercial Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Anthony Romanos
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW